Eli Lillys booth at ASH 2025 prominently featuring Jaypirca
Pharma

Lilly’s BTK drug Jaypirca enters first-line CLL

Despite a positive first-line readout, Lilly’s Jake Van Naarden has maintained that the primary use of Jaypirca “remains in second line.”
Angus Liu Oct 2, 2026 4:15pm
Its a Jungle Out There Hiring for Resilience in Life Sciences Sales

Hiring for Resilience in Life Sciences Sales

Brought to you by Mix Talent
Bayer Bayer Ohio New Albany

Bayer doubles down on US with $2.2B Ohio manufacturing project

Oct 2, 2026 3:10pm
Two hands with vitiligo holding each other

Litfulo and tilrekimig data bolster Pfizer's immunology plans

Oct 2, 2026 11:15am
Podcast
Graphic for The Top Line podcast featuring a pale blue background with a repeating pattern of blue-and-white capsules a

Locking in on pharma’s consumerization trend

Oct 2, 2026 10:36am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Foundayo surges as Wegovy pill stalls

Oct 2, 2026 10:20am
More News

Regulatory tracker: Camzyos wins pediatric nod at FDA

Oct 2, 2026 10:10am

Teva, Samsung Bioepis deepen biosimilar bonds with new deal

Oct 2, 2026 10:00am

AZ-Summit, Novo-Hengrui, Merck—Fierce Pharma Asia

Oct 2, 2026 9:35am

Genentech amplifies breast cancer conversations in new campaign

Oct 1, 2026 2:52pm